Chronic kidney disease: a marker of cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Chronic kidney disease (CKD) patients face a substantially elevated risk of developing cardiovascular disease (CVD).
• Cardiovascular complications are a leading cause of morbidity and mortality in the CKD population.
• Multiple contributing factors to CVD in CKD include hypertension, anemia, inflammation, and metabolic imbalances.

Purpose of the Study:

• To highlight the critical link between CKD and CVD.
• To emphasize the need for early identification and management of CVD risk factors in CKD patients.
• To advocate for the inclusion of specific early CVD markers in routine patient evaluations.

Main Methods:

• Review of existing literature on CVD risk factors in CKD.
• Identification of key contributing factors to CVD in CKD patients.
• Recommendation for specific screening tools and early markers for CVD detection.

Main Results:

• CKD patients exhibit high rates of cardiovascular complications.
• Hypertension, anemia, inflammation, hyperlipidemia, mineral imbalances, and hyperuricemia are significant contributors to CVD in CKD.
• Early markers like microalbuminuria and uric acid, along with eGFR, are vital for risk assessment.

Conclusions:

• Aggressive management of contributing factors is essential to improve survival in CKD patients with CVD risk.
• Routine annual evaluation should incorporate early CVD markers, especially for high-risk groups (diabetics, hypertensives, smokers, elderly).
• Estimated Glomerular Filtration Rate (eGFR) is a recommended screening tool for identifying at-risk individuals.